Page last updated: 2024-10-24

bupranolol and Vertigo

bupranolol has been researched along with Vertigo in 1 studies

Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.

Vertigo: An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1)

Research Excerpts

ExcerptRelevanceReference
"52 patients with acute neurotic anxious and psychosomatic syndromes or chronic anxious and vegetative neuroses were treated orally with the combination drug Betamed (1 tablet contain 60 mg bupranolol and 2."5.05[Betamed in the treatment of psychogenic disorders with a somatic component]. ( Jellinger, K, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jellinger, K1

Trials

1 trial available for bupranolol and Vertigo

ArticleYear
[Betamed in the treatment of psychogenic disorders with a somatic component].
    Wiener medizinische Wochenschrift (1946), 1983, Sep-30, Volume: 133, Issue:18

    Topics: Adolescent; Adult; Aged; Anxiety Disorders; Bupranolol; Clinical Trials as Topic; Diazepam; Drug Adm

1983